These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 781755)

  • 1. [Changes of lipid metabolism in nephrotic patients].
    Gaspar ML; Fontanals JM; Ribes EA
    Rev Clin Esp; 1976 Apr; 141(1):7-10. PubMed ID: 781755
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in serum lipoproteins in kidney diseases. Therapeutic possibilities].
    Walther A; Mordasini R; Riesen W
    Dtsch Med Wochenschr; 1983 Mar; 108(10):388. PubMed ID: 6337805
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia.
    Kleinknecht D; Laudat MH; Strauch G; Jungers P; Laudat P
    Rev Eur Etud Clin Biol; 1972 Jan; 17(1):27-37. PubMed ID: 5041347
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid abnormalities in renal disease.
    Simon NM; Del Greco F
    Ann Clin Lab Sci (1971); 1972; 2(3):186-90. PubMed ID: 4343276
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the pathochemical characteristics of experimental nephrotic syndrome].
    Nikiforova NV
    Vopr Med Khim; 1967; 13(1):69-73. PubMed ID: 4178088
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL; Packard CJ
    Nephrol Dial Transplant; 1993; 8(5):385-96. PubMed ID: 8393541
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
    In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid metabolism in kidney diseases].
    Yoshitoshi Y; Naito C
    Naika; 1968 Oct; 22(4):824-30. PubMed ID: 4884620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipolytic activity of kidney tissue in experimental nephrotic syndrome].
    Leĭtes SM; Nikiforova NV
    Vopr Med Khim; 1967; 13(4):404-8. PubMed ID: 5598540
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology and clinical aspects of lipid metabolism disorders. Physiopathology of lipid metabolism from the clinical viewpoint].
    Haller H; Hanefeld M; Leonhardt W
    Dtsch Gesundheitsw; 1971 Sep; 26(36):1673-9. PubMed ID: 4940280
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of nephrotic syndrome.
    Arneil GC
    Turk J Pediatr; 1973 Jan; 15(1):52-66. PubMed ID: 4616430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in serum lipoproteins in kidney diseases].
    Mordasini R; Riesen W
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolism in acute and chronic renal failure.
    Losowsky MS; Kenward DH
    J Lab Clin Med; 1968 May; 71(5):736-43. PubMed ID: 5647680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the role of the serum lipoproteins in transporting free fatty acids in lipid metabolism disorders in arteriosclerosis and nephrotic syndrome].
    WASOWSKA-CISZEK T
    Pol Arch Med Wewn; 1962; 32():1579-91. PubMed ID: 13999041
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance.
    Wardle EN; Menon IS; Anderson J
    Q J Med; 1972 Jan; 41(161):15-23. PubMed ID: 5070986
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.